• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Tachycardia (2095); Thromboembolism (2654)
Event Date 10/10/2021
Event Type  Injury  
Event Description
A journal article was submitted detailing a case report of a patient who underwent venaseal procedure for the treatment of varicose veins.7 days post procedure the patient felt chest pain and had slight shortness of breath while walking.The patient returned to the outpatient clinic for follow-up.The appearance of the bil.Lower limb was normal.In this case, both lower extremity veins underwent ultrasound examination, no thrombus was found in the deep venous system, and the great saphenous vein was closed at a distance of 5 cm from the junction of the common femoral vein.Electrocardiography revealed sinus tachycardia and a right ventricular strain pattern.For further confirm the diagnosis, the patient underwent chest computed tomography angiography.The results of the study showed that pulmonary thromboembolism occurred in the bilateral pulmonary arteries, and the severity of the right side was much greater than that of the left side.Patient was admitted to icu and systemic urokinase thrombolysis was administered.Enoxaparin for 7 days and rivaroxaban for 3 months were prescribed subsequently for anticoagulation.After 7 days of treatment, the patient¿s symptoms improved significantly, and the pulmonary embolism was also significantly improved by computer tomography angiography.The patient was transferred to the general ward and was discharged in a stable condition.Three months later, the pulmonary embolism under computerized angiography completely disappeared.The patient stopped taking anticoagulant drugs and followed up for 6 months without recurrence.
 
Manufacturer Narrative
Title: a rare case of pulmonary thromboembolism without deep vein thrombosis after nonthermal nontumescent ablative methods for varicose vein surgery author: chih-chien yen journal: annals of vascular surgery year: 2021 vol/issue: 79 ref: doi.Org/10.1016/j.Avsg.2021.07.036.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key13660488
MDR Text Key290558566
Report Number9612164-2022-00873
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeTW
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/01/2022
Initial Date FDA Received03/03/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age66 YR
Patient SexFemale
-
-